Skyhawk Therapeutics

Skyhawk Therapeutics

  • Founded: 2018
  • Location: Waltham, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin0
  • Therapy area: Neurodegenerative condition
  • Drug types: NEU, ONC, MUS, IMM
  • Lead product: Undisclosed
  • Product link:
  • Funding: $133M Sep 2021; $40M A Jul 2018; $8M seed Jan 2018

job board

Short description:

RNA-correcting Small Molecules

Drug notes:

16 additional undisclosed programs RD/Clin0 autoimmune conditions, oncology, muscular & neuromuscular conditions, neurodegenerative conditions

Long description:

Contact us to add description.


Skyhawk Therapeutics
Senior Research Associate
Basel, BS|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy